ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2014

Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels.

Chien-Chun Steven Pai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.